{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BI+1744+CL", "query": { "intervention": "BI 1744 CL" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 35, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BI+1744+CL&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-12T06:08:37.469Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03265145", "title": "Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "ICS (Inhaled Corticosteroid) (Triple therapy)", "type": "DRUG" }, { "name": "LABA (Long-Acting Beta Agonist) (Triple therapy)", "type": "DRUG" }, { "name": "LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 714, "start_date": "2017-09-20", "completion_date": "2020-09-30", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 90, "location_summary": "Mobile, Alabama • Montgomery, Alabama • Tucson, Arizona + 84 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Apple Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03265145" }, { "nct_id": "NCT01525615", "title": "A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Respimat inhaler", "type": "DEVICE" }, { "name": "tiotropium+olodaterol (low dose)", "type": "DRUG" }, { "name": "tiotropium + olodaterol (high dose)", "type": "DRUG" }, { "name": "placebo to tiotropium+olodaterol", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 404, "start_date": "2012-02", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-08-29", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 15, "location_summary": "Torrance, California • Hartford, Connecticut • Springfield, Illinois + 12 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Livonia", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525615" }, { "nct_id": "NCT04223843", "title": "A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium + olodaterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 213, "start_date": "2020-01-08", "completion_date": "2020-09-29", "has_results": true, "last_update_posted_date": "2021-11-18", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 21, "location_summary": "Andalusia, Alabama • Jasper, Alabama • Brandon, Florida + 18 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Brandon", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04223843" }, { "nct_id": "NCT01559116", "title": "Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 219, "start_date": "2012-03", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 4, "location_summary": "Jasper, Alabama • Easley, South Carolina • Greenville, South Carolina + 1 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Easley", "state": "South Carolina" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01559116" }, { "nct_id": "NCT04138758", "title": "Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COPD" ], "interventions": [ { "name": "Tiotropium bromide + Olodaterol", "type": "DRUG" }, { "name": "LABA/ICS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 42953, "start_date": "2019-11-01", "completion_date": "2019-11-04", "has_results": true, "last_update_posted_date": "2021-11-15", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 1, "location_summary": "Watertown, Massachusetts", "locations": [ { "city": "Watertown", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04138758" }, { "nct_id": "NCT04926233", "title": "Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium bromide + Olodaterol", "type": "DRUG" }, { "name": "Sp(t)iolto® Respimat®", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1371146, "start_date": "2019-11-15", "completion_date": "2020-04-14", "has_results": true, "last_update_posted_date": "2021-11-15", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04926233" }, { "nct_id": "NCT00452400", "title": "Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive", "Asthma" ], "interventions": [ { "name": "BI 1744CL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 409, "start_date": "2007-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Lakewood, California • Denver, Colorado + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Lakewood", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452400" }, { "nct_id": "NCT02845752", "title": "The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "Placebo Respimat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 14, "start_date": "2017-03-01", "completion_date": "2018-08-06", "has_results": true, "last_update_posted_date": "2020-08-06", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02845752" }, { "nct_id": "NCT01040728", "title": "A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol (BI1744) Low", "type": "DRUG" }, { "name": "Olodaterol (BI1744) High", "type": "DRUG" }, { "name": "Tiotropium 18 mcg", "type": "DRUG" }, { "name": "Placebo (for Olodaterol (BI1744)l)", "type": "DRUG" }, { "name": "Placebo (for Tiotropium)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 122, "start_date": "2010-01", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-30", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 3, "location_summary": "Jasper, Alabama • Clearwater, Florida • Tampa, Florida", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01040728" }, { "nct_id": "NCT00782210", "title": "12 / 48 Week Pivotal PFT vs PBO in COPD I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol (BI1744)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 625, "start_date": "2008-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-12T06:08:37.469Z", "location_count": 21, "location_summary": "Jasper, Alabama • Berkeley, California • Los Angeles, California + 17 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Berkeley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Stamford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782210" } ] }